Tobias Bald Selected Research

Tobias Bald Research Topics

Disease

23	Neoplasms (Cancer) 11/2022 - 08/2009
17	Melanoma (Melanoma, Malignant) 11/2022 - 08/2009
8	Inflammation (Inflammations) 01/2021 - 10/2012
2	Neoplasm Metastasis (Metastasis) 12/2017 - 01/2017
2	Contact Dermatitis (Eczema, Contact) 06/2014 - 05/2013
1	Carcinoma (Carcinomatosis) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Viral Bronchiolitis 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	COVID-19 01/2021
1	Cytokine Release Syndrome 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Vascular Tissue Neoplasms 01/2021
1	Chronic Disease (Chronic Diseases) 10/2020
1	Visceral Leishmaniasis (Kala Azar) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019
1	Multiple Myeloma 01/2018
1	Disease Progression 01/2018
1	Pathologic Neovascularization 11/2016
1	Amelanotic Melanoma (Amelanotic Melanomas) 01/2016
1	Neurofibrosarcoma (MPNST) 01/2016
1	Skin Neoplasms (Skin Cancer) 10/2015
1	Papilloma (Papillomatosis) 10/2015
1	Fibrosarcoma 10/2015
1	Atopic Dermatitis (Atopic Eczema) 06/2014
1	Dermatitis 06/2014
1	Autoimmune Diseases (Autoimmune Disease) 09/2013
1	Infections 09/2013
1	Bites and Stings (Sting) 09/2013
1	Allergic Contact Dermatitis 05/2013
1	Necrosis 10/2012

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2017
5	AntigensIBA 01/2021 - 08/2009
5	CytokinesIBA 01/2020 - 10/2012
4	LigandsIBA 11/2022 - 10/2017
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	ChemokinesIBA 01/2020 - 07/2011
3	CannabinoidsIBA 10/2015 - 05/2013
2	C-Reactive ProteinIBA 01/2022 - 01/2022
2	InterleukinsIBA 01/2021 - 01/2018
2	PlasticsIBA 01/2021 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2017
2	Interleukin-18 (Interleukin 18)IBA 01/2020 - 01/2018
2	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 01/2017
2	EnzymesIBA 01/2017 - 01/2017
2	CarcinogensIBA 02/2016 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 09/2013
1	Biological ProductsIBA 11/2022
1	Interferon LambdaIBA 01/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2021
1	Poly I-CIBA 01/2021
1	apabetaloneIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 10/2020
1	src-Family KinasesIBA 10/2020
1	Interferon Type IIBA 01/2020
1	EpitopesIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 12/2019
1	InflammasomesIBA 12/2019
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2017
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2017
1	dabrafenibIBA 01/2017
1	trametinibIBA 01/2017
1	Netrin-1IBA 11/2016
1	Netrin ReceptorsIBA 11/2016
1	Phorbol EstersIBA 02/2016
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2016
1	Chemotactic FactorsIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 11/2015
1	Dronabinol (THC)FDA LinkGeneric 10/2015
1	CB2 Cannabinoid ReceptorIBA 10/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 06/2014
1	isothiocyanic acidIBA 06/2014
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 06/2014
1	Fluorescein-5-isothiocyanate (FITC)IBA 06/2014
1	Antiviral Agents (Antivirals)IBA 09/2013
1	Nucleic AcidsIBA 08/2009

Therapy/Procedure

15	Immunotherapy 11/2022 - 10/2012
10	Therapeutics 01/2021 - 10/2012
2	Transplantation 01/2015 - 10/2012
2	Injections 06/2014 - 08/2009
1	ACT protocol 10/2012